| Product NDC: | 0378-1160 |
| Proprietary Name: | Guanfacine |
| Non Proprietary Name: | guanfacine Hydrochloride |
| Active Ingredient(s): | 1 mg/1 & nbsp; guanfacine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-1160 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074796 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120327 |
| Package NDC: | 0378-1160-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0378-1160-01) |
| NDC Code | 0378-1160-01 |
| Proprietary Name | Guanfacine |
| Package Description | 100 TABLET in 1 BOTTLE (0378-1160-01) |
| Product NDC | 0378-1160 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | guanfacine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120327 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | GUANFACINE HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |